Nutex Health (NUTX) Competitors $114.61 -3.00 (-2.55%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$115.35 +0.74 (+0.65%) As of 07/11/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NUTX vs. PAYO, EVTC, APLD, RAMP, FIVN, PLTK, PINC, UPWK, DFIN, and XMTRShould you be buying Nutex Health stock or one of its competitors? The main competitors of Nutex Health include Payoneer Global (PAYO), Evertec (EVTC), Applied Digital (APLD), LiveRamp (RAMP), Five9 (FIVN), Playtika (PLTK), Premier (PINC), Upwork (UPWK), Donnelley Financial Solutions (DFIN), and Xometry (XMTR). These companies are all part of the "business services" industry. Nutex Health vs. Its Competitors Payoneer Global Evertec Applied Digital LiveRamp Five9 Playtika Premier Upwork Donnelley Financial Solutions Xometry Payoneer Global (NASDAQ:PAYO) and Nutex Health (NASDAQ:NUTX) are both business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations, media sentiment and dividends. Is PAYO or NUTX more profitable? Payoneer Global has a net margin of 11.32% compared to Nutex Health's net margin of 10.76%. Nutex Health's return on equity of 42.08% beat Payoneer Global's return on equity.Company Net Margins Return on Equity Return on Assets Payoneer Global11.32% 15.70% 1.53% Nutex Health 10.76%42.08%11.80% Do insiders and institutionals have more ownership in PAYO or NUTX? 82.2% of Payoneer Global shares are owned by institutional investors. Comparatively, 5.3% of Nutex Health shares are owned by institutional investors. 2.6% of Payoneer Global shares are owned by insiders. Comparatively, 36.9% of Nutex Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has better earnings and valuation, PAYO or NUTX? Payoneer Global has higher revenue and earnings than Nutex Health. Nutex Health is trading at a lower price-to-earnings ratio than Payoneer Global, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPayoneer Global$977.72M2.40$121.16M$0.3021.60Nutex Health$479.95M1.33$52.18M$11.899.64 Does the media prefer PAYO or NUTX? In the previous week, Nutex Health had 3 more articles in the media than Payoneer Global. MarketBeat recorded 7 mentions for Nutex Health and 4 mentions for Payoneer Global. Payoneer Global's average media sentiment score of 0.85 beat Nutex Health's score of 0.43 indicating that Payoneer Global is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Payoneer Global 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nutex Health 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend PAYO or NUTX? Payoneer Global currently has a consensus price target of $10.44, indicating a potential upside of 61.07%. Nutex Health has a consensus price target of $262.50, indicating a potential upside of 129.04%. Given Nutex Health's higher probable upside, analysts plainly believe Nutex Health is more favorable than Payoneer Global.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Payoneer Global 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.00Nutex Health 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more risk & volatility, PAYO or NUTX? Payoneer Global has a beta of 0.98, suggesting that its stock price is 2% less volatile than the S&P 500. Comparatively, Nutex Health has a beta of -0.04, suggesting that its stock price is 104% less volatile than the S&P 500. SummaryPayoneer Global beats Nutex Health on 10 of the 16 factors compared between the two stocks. Get Nutex Health News Delivered to You Automatically Sign up to receive the latest news and ratings for NUTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NUTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NUTX vs. The Competition Export to ExcelMetricNutex HealthMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$636.67M$7.32B$5.55B$9.09BDividend YieldN/A2.84%5.25%4.02%P/E Ratio9.6434.5428.2620.27Price / Sales1.3335.94408.79151.98Price / Cash8.7023.1337.1257.67Price / Book3.096.858.045.49Net Income$52.18M$236.02M$3.19B$250.45M7 Day Performance-4.01%0.01%3.62%4.79%1 Month Performance-6.27%2.76%5.98%9.59%1 Year Performance2,169.50%33.80%29.39%16.41% Nutex Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NUTXNutex Health2.6358 of 5 stars$114.61-2.6%$262.50+129.0%+2,169.5%$636.67M$479.95M9.641,150High Trading VolumePAYOPayoneer Global3.9194 of 5 stars$6.68-4.3%$10.44+56.3%+23.0%$2.52B$977.72M22.272,407EVTCEvertec2.4021 of 5 stars$37.07-1.2%$40.00+7.9%+3.2%$2.39B$845.49M18.634,800APLDApplied Digital4.0132 of 5 stars$9.66-7.6%$12.73+31.8%+48.1%$2.35B$165.57M-7.05121Analyst RevisionRAMPLiveRamp4.7621 of 5 stars$33.32-0.7%$40.67+22.0%+0.3%$2.18B$745.58M-3,332.001,300News CoverageAnalyst ForecastFIVNFive94.122 of 5 stars$27.81+0.4%$43.15+55.2%-39.2%$2.11B$1.04B-308.973,073Positive NewsPLTKPlaytika4.3364 of 5 stars$4.84-2.4%$7.68+58.6%-40.3%$1.86B$2.55B12.743,500Positive NewsPINCPremier1.935 of 5 stars$22.000.0%$22.20+0.9%+12.2%$1.81B$1.35B38.602,900Positive NewsUPWKUpwork3.6472 of 5 stars$13.45-1.4%$18.67+38.8%+13.4%$1.79B$769.33M8.05850DFINDonnelley Financial Solutions2.2918 of 5 stars$63.69+0.1%$71.33+12.0%+6.8%$1.76B$781.90M21.091,800News CoveragePositive NewsXMTRXometry2.5597 of 5 stars$33.69-2.3%$35.78+6.2%+150.5%$1.75B$545.53M-34.031,088Positive News Related Companies and Tools Related Companies Payoneer Global Alternatives Evertec Alternatives Applied Digital Alternatives LiveRamp Alternatives Five9 Alternatives Playtika Alternatives Premier Alternatives Upwork Alternatives Donnelley Financial Solutions Alternatives Xometry Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NUTX) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutex Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutex Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NUTX Stock Alerts